Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) filed a Form 8-K with the Securities and Exchange Commission on January 20, 2026, disclosing a material event.
Quoin Pharmaceuticals, Ltd.'s stock currently trades at $10.45 with a market capitalization of $6,540,406. The Healthcare company's stock moved following the disclosure.